<DOC>
	<DOC>NCT02833545</DOC>
	<brief_summary>Prospective, Interventional, Non-Randomized, Open Label, Single Group Assignment, Single Center.</brief_summary>
	<brief_title>Safety and Efficacy of Intra-articular Ozone Injections for Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>55 to 79 years of age Symptomatic Knee osteoarthritis VAS pain intensity is at least 40 mm on a 100 mm scale Must be physically and mentally willing and able to comply with postoperative rehabilitation and routinely schedule clinical and radiographic visits. Any known tumor of the ipsilateral knee. Any known infection of the treated knee. Osteoarthritis of the operated knee Kelgren Lawrence &lt; grade 2. Chemotherapy treatment in the past 12 months. Patients who are sensitive to ozone. Pregnant women, or breastfeeding women. Evidence of any significant systemic disease (such as but not limited to HIV infection, hepatitis infection or HTLV infection), known coagulopathies, that might compromise the Subject's welfare. Substance abuse or alcohol abuse. Participation in other clinical trials in parallel to this study.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>